Skip to main content

#153422

H357 Cell Line

Cat. #153422

H357 Cell Line

Cat. #: 153422

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Tissue: Tongue

Disease: Cancer

Model: Tumourigenic cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Stephen Prime

Institute: University of Bristol

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: H357 Cell Line
  • Alternate name: H-357; h357
  • Research fields: Cancer
  • Tissue: Tongue
  • Disease: Cancer
  • Growth properties: Adherent
  • Model: Tumourigenic cell line
  • Conditional: Yes
  • Description: H357 was established from a squamous cell carcinoma (SCC) of the tongue (20mm) of a 74 year-old male patient. H357 has the following features: polygonal morphology, STNMP stage I, well differentiated and node negative tumour. This cell line has mutant p53, codon 110 exon 4, G to A; the previously reported mutant Ha-ras status of this cell line: codon: 13, G to A, codon 61, A-G is under investigation. H357 is highly responsive to TGF beta and undergoes epithelial to mesenchymal transition. H357 cells are tumourigenic in athymic nude mice on subcutaneous injection and non-tumourigenic on orthotopic injection. Haplotype information: A*02,A*31; B*40,B*44; Cw*03,Cw*05. Explore more human oral SCC cell lines from the same inventor including: H157, H376, H400, H314 and H103.
  • Cellosaurus id: CVCL_2462

Target Details

  • Target: Human oral squamous cell carcinoma, tongue

Handling

  • Format: Frozen
  • Growth medium: DMEM:HAMS F12 (1:1) + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) + 0.5 ug/ml sodium hydrocortisone succinate.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Subculture routine: Split sub-confluent cultures (70-80%), approximately every 5-6 days, 1:8 to 1:10 using 0.05% trypsin/EDTA; 5% CO₂; 37°C. Suggested seeding density of 5 x 1000 cells/cm². Cells can take approximately 10 minutes to detach, an alternative is to trypsinise 2 to 3 times with fresh trypsin for shorter periods for each trypsin application. Avoid knocking flasks during the trypsinisation process as this can lead to loss of viability.

References

  • Fahey et al. 1996. Br J Cancer. 74(7):1074-80. PMID: 8855977.
  • Yeudall et al. 1995. Eur J Cancer B Oral Oncol. 31(2):136-143. PMID: 7633286.
  • Prime et al. 1994. Int J Cancer. 56(3):406-412. PMID: 7508893.
  • Prime et al. 1994. Br J Cancer. 69(1):8-15. PMID: 8286215.
  • Yeudall et al. 1993. Eur J Cancer B Oral Oncol. 29B(1):63-67. PMID: 8180579.
  • Prime et al. 1990. J Pathol. 160(3):259-269. PMID: 1692339.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.